Repligen Corp. (RGEN)

Last Three Months

25-Aug-24 -- 24-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

31

0

2

+1

0

+2

0

+3

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Nov-24 2:29 PM View:	19-Nov-24 Option Exercise $689.51K	Muir Glenn P Director		Repligen Corp. - RGEN	143% 13.28K to 32.28K	0	0	--	--	Show Txns Hide Txns

21-Nov-24 2:10 PM View:	20-Nov-24 Payment of Exercise ($45.29K)	Garland Jason K CFO		Repligen Corp. - RGEN	(5%) 8.04K to 7.68K	0	0	--	--	Show Txns Hide Txns

12-Sep-24 11:35 AM View:	10-Sep-24 Sale ($1.77M)	Hunt Anthony Director		Repligen Corp. - RGEN	(15%) 165.18K to 139.84K	0	0	--	--	Show Txns Hide Txns

21-Nov-24 1:32 PM View:	20-Nov-24 Payment of Exercise ($106.26K)	Loeillot Olivier Chief Executive Officer Director		Repligen Corp. - RGEN	106% 15.79K to 32.56K	0	0	--	--	Show Txns Hide Txns